SeqOnce Biosciences Competitors and Similar CompaniesClear all

SeqOnce Biosciences's competitors and similar companies include Invitae, Yposkesi, US Biomax and 4Basebio.

	SeqOnce Biosciences SeqOnce Biosciences is a company engaged in Next Generation Sequencing (NGS) sample processing and manufacturing.	Invitae Invitae is a company engaged in medical genetic testing.	Yposkesi Yposkesi is a contract development and manufacturing organization specializing in gene therapy viral vector manufacturing.	US Biomax US Biomax is a company that provides human tissue microarray products and related services.	4Basebio 4Basebio (formerly Expedeon) is a company that specializes in the manufacture and distribution of pharmaceutical grade DNA products.
Founding Date	Founding Date 2014	Founding Date 2010	Founding Date 2016	Founding Date 2004	Founding Date 1997
Type	Type Private	Type Subsidiary	Type Private	Type Private	Type Public
Tags	Tags Manufacturing & Industrial biotech distribution genetics	Tags Healthcare biotech genetics medical diagnostics	Tags Manufacturing & Industrial biotech contractor genetics	Tags Manufacturing & Industrial biotech genetics	Tags Healthcare biotech distribution genetics
Locations	Locations Pasadena, US HQ	Locations San Francisco, US HQ	Locations Paris, FR HQ	Locations Derwood, US HQ Rockville, US	Locations Cambridge, GB HQ
Employees	Employees 9	Employees 8601% decrease	Employees 1481% increase	Employees 3	Employees 1
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $516.3m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $417.3m (FY, 2022)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $99m (FY, 2022)	Gross profit N/A	Gross profit N/A	Gross profit €869k (FY, 2025)
Net income	Net income N/A	Net income ($3.1b) (FY, 2022)	Net income N/A	Net income N/A	Net income €3.4m (FY, 2025)